NCT00498927 2016-02-29
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)